共 18 条
- [1] Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction, Lancet, 1, pp. 397-401, (1986)
- [2] Randomized trial of intravenous streptokinase oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2, Lancet, 2, pp. 349-360, (1988)
- [3] Wilcox, Olsson, Skene, Et al., Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction, Lancet, 2, pp. 525-530, (1988)
- [4] Van der Werf, Arnold, Intravenous tissue plasminogen activator and size of infarct left ventricular function and survival in acute myocardial infarction, BMJ, 297, pp. 1374-1379, (1988)
- [5] Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial, Lancet, 1, pp. 545-549, (1988)
- [6] Koren, Weiss, Hasin, Et al., Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase, N Engl J Med, 313, pp. 1384-1389, (1985)
- [7] Kennedy, Martin, Davis, Et al., The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction randomized trial, Circulation, 77, pp. 345-352, (1988)
- [8] Sharkey, Brunette, Ruiz, Et al., An analysis of time delays preceding thrombolysis for acute myocardial infarction, JAMA, 262, pp. 3171-3174, (1989)
- [9] Weaver, Eisenberg, Martin, Et al., Myocardial Infarction Triage and Intervention Project—Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy, J Am Coll Cardiol, 15, pp. 925-931, (1990)
- [10] Ornato, Role of emergency department in decreasing the time to thrombolytic therapy in acute myocardial infarction, Clin Cardiol, 13, pp. 48-52, (1990)